Revenue of local laboratories grows 19% until April and outperforms market

The national pharmaceutical companies saw your billing with generic drugs at retail up 19% from January to April compared with the same period last year. With this performance, surpassed the sum of all categories – which includes multinationals and importers, whose expansion was 13%. Still climbed 60 percent slice of sales in pharmacies and drugstores, as well as answering for 70% of total sales of generic drugs.